Your browser doesn't support javascript.
loading
The pathogenic role of the BRCA2 c.7847C>T (p.Ser2616Phe) variant in breast and ovarian cancer predisposition.
Yamazawa, Kazuki; Sugano, Kokichi; Tanakaya, Kohji; Inoue, Satomi; Murakami, Haruka; Nakashima, Moeko; Adachi, Masataka; Oki, Shinya; Makabe, Takeshi; Yamashita, Hiroshi; Ueki, Arisa; Sasaoka, Ayako; Nakashoji, Ayako; Kinoshita, Takayuki; Matsunaga, Tatsuo; Arai, Masami; Nakamura, Seigo; Miyata, Hiroaki; Ikegami, Masachika; Mano, Hiroyuki; Kohsaka, Shinji; Matsui, Akira.
Afiliação
  • Yamazawa K; Department of Medical Genetics, National Hospital Organization Tokyo Medical Center, Tokyo, Japan.
  • Sugano K; Department of Genetic Medicine, Sasaki Foundation, Kyoundo Hospital, Tokyo, Japan.
  • Tanakaya K; Department of Genetic Medicine and Services, National Cancer Center Hospital, Tokyo, Japan.
  • Inoue S; Department of Surgery, National Hospital Organization Iwakuni Clinical Center, Iwakuni, Japan.
  • Murakami H; Department of Medical Genetics, National Hospital Organization Tokyo Medical Center, Tokyo, Japan.
  • Nakashima M; Department of Medical Genetics, National Hospital Organization Tokyo Medical Center, Tokyo, Japan.
  • Adachi M; Department of Medical Genetics, National Hospital Organization Tokyo Medical Center, Tokyo, Japan.
  • Oki S; Department of Medical Genetics, National Hospital Organization Tokyo Medical Center, Tokyo, Japan.
  • Makabe T; Department of Obstetrics and Gynecology, National Hospital Organization Tokyo Medical Center, Tokyo, Japan.
  • Yamashita H; Department of Medical Genetics, National Hospital Organization Tokyo Medical Center, Tokyo, Japan.
  • Ueki A; Department of Obstetrics and Gynecology, National Hospital Organization Tokyo Medical Center, Tokyo, Japan.
  • Sasaoka A; Department of Medical Genetics, National Hospital Organization Tokyo Medical Center, Tokyo, Japan.
  • Nakashoji A; Department of Obstetrics and Gynecology, National Hospital Organization Tokyo Medical Center, Tokyo, Japan.
  • Kinoshita T; Department of Obstetrics and Gynecology, National Hospital Organization Tokyo Medical Center, Tokyo, Japan.
  • Matsunaga T; Division of Clinical Genetic Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Arai M; Department of Nursing, National Hospital Organization Tokyo Medical Center, Tokyo, Japan.
  • Nakamura S; Department of Breast Surgery, National Hospital Organization Tokyo Medical Center, Tokyo, Japan.
  • Miyata H; Department of Breast Surgery, National Hospital Organization Tokyo Medical Center, Tokyo, Japan.
  • Ikegami M; Department of Medical Genetics, National Hospital Organization Tokyo Medical Center, Tokyo, Japan.
  • Mano H; Department of Clinical Genetics, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
  • Kohsaka S; Division of Breast Surgical Oncology, Department of Surgery, Showa University School of Medicine, Tokyo, Japan.
  • Matsui A; Department of Health Policy and Management, Keio University School of Medicine, Tokyo, Japan.
Cancer Sci ; 114(7): 2993-3002, 2023 Jul.
Article em En | MEDLINE | ID: mdl-37067535
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias da Mama Tipo de estudo: Guideline / Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias da Mama Tipo de estudo: Guideline / Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article